These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
5. Combining genetics, neuropsychology and neuroimaging to improve understanding of brain involvement in Duchenne muscular dystrophy - a narrative review. Doorenweerd N Neuromuscul Disord; 2020 Jun; 30(6):437-442. PubMed ID: 32522501 [TBL] [Abstract][Full Text] [Related]
6. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. Hoffman EP FEBS J; 2020 Sep; 287(18):3879-3887. PubMed ID: 32608079 [TBL] [Abstract][Full Text] [Related]
7. A possible role of dystrophin in neuronal excitability: a review of the current literature. Hendriksen RG; Hoogland G; Schipper S; Hendriksen JG; Vles JS; Aalbers MW Neurosci Biobehav Rev; 2015 Apr; 51():255-62. PubMed ID: 25677308 [TBL] [Abstract][Full Text] [Related]
8. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404 [TBL] [Abstract][Full Text] [Related]
9. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Klymiuk N; Blutke A; Graf A; Krause S; Burkhardt K; Wuensch A; Krebs S; Kessler B; Zakhartchenko V; Kurome M; Kemter E; Nagashima H; Schoser B; Herbach N; Blum H; Wanke R; Aartsma-Rus A; Thirion C; Lochmüller H; Walter MC; Wolf E Hum Mol Genet; 2013 Nov; 22(21):4368-82. PubMed ID: 23784375 [TBL] [Abstract][Full Text] [Related]
10. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627 [TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy]. Sokolova MG; Lobzin SV; Nikishina OA; Kiselev AV; Rezvantsev MV; Litvinenko IV; Gavrichenko AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):78-84. PubMed ID: 29376988 [TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833 [TBL] [Abstract][Full Text] [Related]
13. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies for Duchenne and Becker dystrophies. Voisin V; de la Porte S Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414 [TBL] [Abstract][Full Text] [Related]
16. Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. Shirokova N; Niggli E J Mol Cell Cardiol; 2013 May; 58():217-24. PubMed ID: 23261966 [TBL] [Abstract][Full Text] [Related]
17. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy. Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998 [TBL] [Abstract][Full Text] [Related]
18. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405 [TBL] [Abstract][Full Text] [Related]
20. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]